Fake Ashoka Bark Being Used In Ayurvedic Medicines

Ghaziabad : Scientists of the Pharmacopoeia Commission for Indian Medicine & Homoeopathy examined  Ashoka bark available in the market. Out of these, more than 15 percent were found to be fake.

Apart from making Ayurvedic medicines, people also use these plants for Ayurvedic treatment at home. In this, Ashoka bark was found to be fake. It is used in many diseases including stomach related diseases, skin diseases, piles, bone related diseases, leucorrhoea.

The Commission’s Chief Scientist Dr. Jayanti A. said that many plants available in the market were brought to the Commission’s laboratory for examination. During the investigation, Ashoka bark available in the market was found to be fake.

She said that Ashoka bark is used by big companies for the manufacture of Ayurvedic medicines. Many times complaints were made by regional officials about this. After this, the Commission’s team examined the Ashoka bark used in markets and companies. Medicines of many big companies have also been examined, in whose samples the use of fake bark has been detected. In this regard, the government as well as the Bureau of Standards have been informed. So that fake plants and medicines can be recovered in time.

Drug inspectors are being trained in the Pharmacopoeia Commission for Indian Medicine & Homoeopathy on how to identify fake medicines and medicinal plants available in the market. So that people’s health is not compromised. During the five-day training programme, apart from identifying plants, they are also given information about their use and application.

Ashoka flowers also cure diseases. The red flowers of Ashoka tree are also a storehouse of medicinal properties. Ashoka tree flowers are a boon for curing skin diseases. It is effective in treating female infertility, uterine disorder, dysentery and various skin diseases. Applying some henna leaves and coconut oil mixed with Ashoka tree flowers provides relief from skin diseases.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?